Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

My Take: 4 Strong Growth Stocks to Buy This Week: https://g.foolcdn.com/editorial/images/757305/tracking-investments-wealth-family-planning.jpg
My Take: 4 Strong Growth Stocks to Buy This Week

Are you looking for new growth stocks for your portfolio? The idea was compelling a week ago when the market was roaring higher. Now, with fresh headwinds blowing, not so much.

Just bear in mind

Got $5,000? These 3 Stocks Are Deep-Value Buys Right Now: https://g.foolcdn.com/editorial/images/756922/a-person-looking-at-a-chart-on-their-laptop.jpg
Got $5,000? These 3 Stocks Are Deep-Value Buys Right Now

A $5,000 investment may not seem a significant amount to some, but it can generate tremendous returns in the long run. If you were to invest in the S&P 500, which averages an annual return of around

Is AbbVie Stock a Buy Now?: https://g.foolcdn.com/editorial/images/756931/a-doctor-looking-at-a-tablet-with-another-person.jpg
Is AbbVie Stock a Buy Now?

Leading healthcare company AbbVie (NYSE: ABBV) appears to be hungry for deals to help it diversify its revenue streams. That's because it will need to become less reliant on Humira, its blockbuster

Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly?: https://g.foolcdn.com/editorial/images/757225/man-with-arms-behind-head-looking-at-laptop.jpg
Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly?

Many investors have flocked to big pharma stocks throughout the years. And doing so has paid off handsomely with several of those stocks.

AbbVie (NYSE: ABBV) and Eli Lilly (NYSE: LLY) stand out as

This Newly Discovered Risk Could Be a Big Headache for Vertex Pharmaceuticals and CRISPR Therapeutics: https://g.foolcdn.com/editorial/images/757061/doctor-explains-paper-to-patient.jpg
This Newly Discovered Risk Could Be a Big Headache for Vertex Pharmaceuticals and CRISPR Therapeutics

In the gene editing therapies space, there aren't any competitors being watched more closely than Vertex Pharmaceuticals (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP). The pair scored

Humana Announces $500K Investment in the Virginia Health Care Foundation to Boost Behavioral Health Workforce Development and Support: https://mms.businesswire.com/media/20231206369536/en/1961226/5/IMG_6514.jpg
Humana Announces $500K Investment in the Virginia Health Care Foundation to Boost Behavioral Health Workforce Development and Support


Leading health and well-being company Humana today announced a meaningful investment of $500,000 in the Virginia Health Care Foundation (VHCF). This funding will bolster crucial behavioral health

Dexcom G7, the Smallest, Most Accurate, Easy-to-Use CGM Now Connects to the Tandem t:slim X2 Insulin Pump: https://mms.businesswire.com/media/20231206143334/en/1959997/5/Dexcom_G7_Tandem_tslim_X2.jpg
Dexcom G7, the Smallest, Most Accurate, Easy-to-Use CGM Now Connects to the Tandem t:slim X2 Insulin Pump


DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now

5 Dividend Stocks That Recently Increased Their Payouts: https://g.foolcdn.com/editorial/images/757263/getty-dividend-stocks-growing-money-income-cash.jpg
5 Dividend Stocks That Recently Increased Their Payouts

My favorite stocks to invest in are those that continuously increase their dividend. Merck & Co (NYSE: MRK) is one stock that I like a lot that has been growing its dividend at a solid clip for a

EQS-Adhoc: Merck KGaA: Phase III trial results for evobrutinib in relapsing multiple sclerosis did not meet primary endpoint of reducing annualized relapse rates (ARR) compared to oral teriflunomide: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23622/Logo_Merck_KGaA_2015.svg.png
EQS-Adhoc: Merck KGaA: Phase III trial results for evobrutinib in relapsing multiple sclerosis did not meet primary endpoint of reducing annualized relapse rates (ARR) compared to oral teriflunomide
EQS-Adhoc: Merck KGaA: Phase III trial results for evobrutinib in relapsing multiple sclerosis did not meet primary endpoint of reducing annualized relapse rates (ARR) compared to oral teriflunomide
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius retains relief payments for hospitals of up to €300 million (from the current perspective) and is therefore subject to a ban on dividends and bonuses for 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24693/Fresenius.svg.png
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius retains relief payments for hospitals of up to €300 million (from the current perspective) and is therefore subject to a ban on dividends and bonuses for 2023
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius retains relief payments for hospitals of up to €300 million (from the current perspective) and is therefore subject to a ban on dividends and bonuses for 2023
A Bull Market Is Coming: 2 Top Stocks to Buy Hand Over Fist: https://g.foolcdn.com/editorial/images/756569/doctor-and-patient-in-a-hospital-room.jpg
A Bull Market Is Coming: 2 Top Stocks to Buy Hand Over Fist

Are we currently in a bull market? Some argue that we are. In early June, the S&P 500 closed 20% up from its most recent low, which is the technical definition of a bull market. However, equities

Humana Foundation Awards Health Equity Research Grants Equal to $1 Million to Three University Partners: https://mms.businesswire.com/media/20231205541539/en/1959439/5/AdobeStock_637447424.jpg
Humana Foundation Awards Health Equity Research Grants Equal to $1 Million to Three University Partners


The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 41 years, today announced the recipients of its first-ever research grants in service of the Foundation’s health

Where Will Vertex Pharmaceuticals Be in 10 Years?: https://g.foolcdn.com/editorial/images/756785/gettyimages-1197547531.jpg
Where Will Vertex Pharmaceuticals Be in 10 Years?

Vertex Pharmaceuticals (NASDAQ: VRTX) has come a long way in the past ten years. In a little over a decade, the company has built a cystic fibrosis (CF) empire, commercializing four drugs for the

Is Pfizer Stock a Buy Now?: https://g.foolcdn.com/editorial/images/756642/gettyimages-904880170.jpg
Is Pfizer Stock a Buy Now?

Stocks have rallied this year, but one of the world's most famous pharma companies didn't join the party. Pfizer (NYSE: PFE), known for its billion-dollar coronavirus products -- the vaccine

Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes: https://g.foolcdn.com/editorial/images/756854/stock-crashing.jpg
Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes

As the year comes to an end, it's time to think about which stocks to sell for tax-loss harvesting. One stock I'm considering letting go is pharma giant Pfizer (NYSE: PFE). The company's shares have

2 Dividend Stocks to Buy and Hold Forever: https://g.foolcdn.com/editorial/images/756237/physician-giving-a-high-five-to-a-young-patient.jpg
2 Dividend Stocks to Buy and Hold Forever

Over long periods, dividend stocks tend to outperform their non-dividend-paying counterparts. There are likely several reasons for this, one of which is that sustaining a dividend program requires a

Why Pfizer Stock Is Sinking Today: https://g.foolcdn.com/editorial/images/756798/scientist-with-head-down.jpg
Why Pfizer Stock Is Sinking Today

Shares of Pfizer (NYSE: PFE) were sinking 4.4% lower as of 11:10 a.m. ET on Friday after falling as much as 7.1% earlier in the morning. The sell-off came after the company announced that it's

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?: https://g.foolcdn.com/editorial/images/756214/patient-sitting-on-hospital-bed.jpg
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Biotech companies CRISPR Therapeutics (NASDAQ: CRSP) and Vertex Pharmaceuticals (NASDAQ: VRTX) are often mentioned in the same sentence. That's because they have been partnering to develop a

AbbVie Should Consider a Dividend Cut -- Here's Why: https://g.foolcdn.com/editorial/images/756473/biotech-researcher.jpg
AbbVie Should Consider a Dividend Cut -- Here's Why

Since its split from Abbott Laboratories in 2013, AbbVie (NYSE: ABBV) has been the third best-performing stock in terms of total returns on capital (assuming the dividend was reinvested) on the

Medtronic Stock: Bull vs. Bear: https://g.foolcdn.com/editorial/images/756304/gettyimages-1276837766.jpg
Medtronic Stock: Bull vs. Bear

Medtronic (NYSE: MDT) is a medical device giant that has generated billions of dollars in earnings over time thanks to its diabetes, cardiovascular, neuroscience, and medical-surgical platforms. The

Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?: https://g.foolcdn.com/editorial/images/756106/time-to-buy.jpg
Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?

Pfizer's (NYSE: PFE) stock performance has been disappointing this year (down 38%). The company has faced multiple challenges, such as declining revenues from COVID-19 products, looming patent

3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later: https://g.foolcdn.com/editorial/images/755957/retired-woman-investing-laptop-401k-ira.jpg
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later

Are you a pro when it comes to procrastination? Some investors take so long to make a decision on buying stocks that they miss out on great upside moves. And when those stocks pay juicy dividends

2 Healthcare Stocks That Could Help Set You Up for Life: https://g.foolcdn.com/editorial/images/755812/physician-giving-medicine-to-elderly-patient.jpg
2 Healthcare Stocks That Could Help Set You Up for Life

Some investors intend to hold shares of the companies they own for good, never having to sell them. This strategy makes sense. Warren Buffett, the man widely regarded as the greatest contemporary

Is Medtronic a Good Dividend Stock to Buy Now?: https://g.foolcdn.com/editorial/images/755922/investor-with-computer-getty.jpg
Is Medtronic a Good Dividend Stock to Buy Now?

If you're looking for reliable dividend stocks, they don't get much better than Medtronic (NYSE: MDT). The medical device company has raised its dividend payout for 46 consecutive years.

From 1978

Could AbbVie Stock Help You Become a Millionaire?: https://g.foolcdn.com/editorial/images/755576/a-group-of-scientists-looking-at-a-report.jpg
Could AbbVie Stock Help You Become a Millionaire?

If you want an investment to make you a millionaire, you need three things. The first is some decent money to invest in the stock market, ideally at least $20,000. The second is time and patience --